Home › NDC Lookup › RxCUI directory › RxCUI 1665093

Cefepime 1000 MG Injection — RxCUI 1665093

RxNorm drug concept · Semantic clinical drug
RxCUI 1665093 Semantic clinical drug · SCD ● Current RxNorm concept 26 FDA products 29 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1665093
Official nameCefepime 1000 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascefepime 1 GM (as cefepime HCl) Injection; cefepime 1 GM Injection
FDA products mapped26
Package NDCs mapped29
Reported Medicaid activity (SDUD)52,968 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefepime Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cefepime is only available as an injection — there's no pill form. It's designed for serious bacterial infections that need a strong antibiotic delivered directly into your bloodst...
  • Why am I getting cefepime through an IV instead of just taking an antibiotic pill?
  • The most common things people notice are redness, pain, or swelling near the injection or IV site, along with rash, nausea, diarrhea, or headache — these are usually manageable. Wh...
  • What side effects should I actually expect, and which ones mean I should speak up right away?
📖 Read our full Cefepime Injection guide →

🕸️ Concept Web — How Cefepime 1000 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cefepime 1000 MG Injection RxCUI 1665093

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cefepime 20481
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cefepime Injection 1665087
    • Cefepime Injectable Product 1160606
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cefepime 1000 MG 1665092

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cefepime 1000 MG SCDC · 1665092
  • Cefepime Injection SCDF · 1665087
  • Cefepime Injectable Product SCDG · 1160606

📦 FDA Products & Package NDCs

26 products · 29 package NDCs
29 package NDCs map to RxCUI 1665093 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9382-10 10 VIAL in 1 CARTON (0143-9382-10) / 1 INJECTION, POWDER, F... Cefepime Hydrochloride Hikma Pharmaceuticals USA Inc. 2025-09-22
00143-9383-10 10 VIAL in 1 CARTON (0143-9383-10) / 1 INJECTION, POWDER, F... Cefepime Hydrochloride Hikma Pharmaceuticals USA Inc. 2025-09-22
00143-9477-10 10 VIAL in 1 CARTON (0143-9477-10) / 1 INJECTION, POWDER, F... Cefepime Hydrochloride Hikma Pharmaceuticals USA Inc. 2025-10-31
00143-9478-10 10 VIAL in 1 CARTON (0143-9478-10) / 1 INJECTION, POWDER, F... Cefepime Hydrochloride Hikma Pharmaceuticals USA Inc. 2025-10-31
00264-3193-11 24 CONTAINER in 1 CASE (0264-3193-11) / 50 mL in 1 CONTAINE... CEFEPIME HYDROCHLORIDE AND DEXTROSE B. Braun Medical Inc. 2010-05-06
00264-3195-11 24 CONTAINER in 1 CASE (0264-3195-11) / 50 mL in 1 CONTAINE... CEFEPIME HYDROCHLORIDE AND DEXTROSE B. Braun Medical Inc. 2010-05-06
00338-1301-41 24 BAG in 1 BOX (0338-1301-41) / 50 mL in 1 BAG Cefepime Baxter Healthcare Corporation 2008-08-05
00338-1301-48 12 BAG in 1 BOX (0338-1301-48) / 100 mL in 1 BAG Cefepime Baxter Healthcare Corporation 2008-08-05
00409-9566-10 10 VIAL in 1 CARTON (0409-9566-10) / 1 INJECTION, POWDER, F... Cefepime Hospira, Inc. 2020-08-24
00409-9735-10 10 VIAL in 1 CARTON (0409-9735-10) / 1 INJECTION, POWDER, F... Cefepime Hospira, Inc. 2020-08-24
25021-0121-20 10 VIAL in 1 CARTON (25021-121-20) / 1 INJECTION, POWDER, F... cefepime Sagent Pharmaceuticals 2008-05-01
25021-0122-50 10 VIAL in 1 CARTON (25021-122-50) / 1 INJECTION, POWDER, F... cefepime Sagent Pharmaceuticals 2008-05-01
44567-0130-10 10 VIAL in 1 CARTON (44567-130-10) / 1 INJECTION, POWDER, F... Cefepime WG Critical Care, LLC 2021-03-31
44567-0131-10 10 VIAL in 1 CARTON (44567-131-10) / 1 INJECTION, POWDER, F... Cefepime WG Critical Care, LLC 2021-03-31
44567-0240-10 10 VIAL in 1 CARTON (44567-240-10) / 1 INJECTION, POWDER, F... Cefepime WG Critical Care, LLC 2014-10-10
44567-0241-10 10 VIAL in 1 CARTON (44567-241-10) / 1 INJECTION, POWDER, F... Cefepime WG Critical Care, LLC 2014-10-10
60505-6144-04 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6144-4) / 1 INJECTI... Cefepime Apotex Corp. 2017-11-14
60505-6145-04 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6145-4) / 1 INJECTI... Cefepime Apotex Corp. 2017-11-14
60505-6146-00 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6146-0) / 1 INJECTIO... Cefepime Apotex Corp. 2017-03-30
60505-6146-04 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6146-4) / 1 INJECTI... Cefepime Apotex Corp. 2017-03-30
60505-6147-00 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6147-0) / 1 INJECTIO... Cefepime Apotex Corp. 2017-03-30
60505-6147-04 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6147-4) / 1 INJECTI... Cefepime Apotex Corp. 2017-03-30
60505-6245-04 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6245-4) / 1 INJECTI... Cefepime Apotex Corp. 2022-09-01
60505-6246-04 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6246-4) / 1 INJECTI... Cefepime Apotex Corp. 2022-09-01
63323-0326-20 10 VIAL in 1 CARTON (63323-326-20) / 1 INJECTION, POWDER, F... Cefepime Fresenius Kabi USA, LLC 2010-08-30
63323-0340-20 10 VIAL in 1 CARTON (63323-340-20) / 1 INJECTION, POWDER, F... Cefepime Fresenius Kabi USA, LLC 2010-08-30
67184-1002-01 10 VIAL in 1 CARTON (67184-1002-1) / 1 INJECTION, POWDER, F... Cefepime Qilu Pharmaceutical Co., Ltd. 2016-02-01
67184-1003-01 10 VIAL in 1 CARTON (67184-1003-1) / 1 INJECTION, POWDER, F... Cefepime Qilu Pharmaceutical Co., Ltd. 2016-02-01
67184-1004-01 10 VIAL in 1 CARTON (67184-1004-1) / 1 INJECTION, POWDER, F... Cefepime Qilu Pharmaceutical Co., Ltd. 2016-02-01
Observed labelers: Apotex Corp. (8) · Hikma Pharmaceuticals USA Inc. (4) · WG Critical Care, LLC (4) · Qilu Pharmaceutical Co., Ltd. (3) · B. Braun Medical Inc. (2) · Baxter Healthcare Corporation (2) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0692 Cefepime hcl for injection 20 CMS
J0701 Inj. cefepime hcl (baxter) 2 CMS
J0703 Inj, cefepime hcl (b braun) 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.